Advisory Solutions Group’s Gilead Sciences GILD Stock Holding History

Advisory Solutions Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$300K	Buy	+2,010	New	+$282K	0.06%	223

Other funds holding GILD

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Advisory Solutions Group's GILD Position: Q3 2026 in Review

Advisory Solutions Group opened a new position in Gilead Sciences (GILD) in Q3 2026: 2,010 shares worth $300K. The stake represents 0.06% of the portfolio and ranks #223 among its holdings.

2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Advisory Solutions Group held 2,010 shares of Gilead Sciences worth $300K as of Q3 2026.
Gilead Sciences was a new Advisory Solutions Group position in Q3 2026.
Gilead Sciences made up 0.06% of Advisory Solutions Group's portfolio in Q3 2026, its #223 holding.
2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Advisory Solutions Group's 13F filing for Q3 2026, filed 14 Oct 2026.